2006Journal of Clinical RadiologyRequires access

Clinic Application with MSCT Perfusion in Liver Tumor

Biao Xu

Open publisher page 3 citations

Abstract

Objective To study the changes of MSCT perfusion parameters of benign or malignancy tumor in liver and discuss differentiate diagnosis.Materials and Methods CT perfusion of the liver were obtained in 100 individuals who include 15 patients with benign tumor and 81 patients with malignancy tumor and 4 as control subjects. Liver perfusion parameters included blood flow (BF), blood volume (BV), mean transit time (MTT), permeability surface (PS) ,Hepatic Perfusion index (HPI) and Hepatic Arterial Perfusion(HAP)were calculated to evaluate the dynamic features of liver tumors.Results Compared with benign tumor of liver and control group, HPI,BF and HAP in malignancy tumor group were increased significantly, and MTT was decreased significantly. BV and PS had no difference between liver tumors and control group.Conclusion Hepatic perfusion parameters (HPI,BF, HAP and MTT) measured with CT can be used to evaluate the dynamic features in liver tumors, which have importance clinic value in differentiate diagnosis of benign or malignancy tumor.

About this research paper

What this paper is about

Objective To study the changes of MSCT perfusion parameters of benign or malignancy tumor in liver and discuss differentiate diagnosis.Materials and Methods CT perfusion of the liver were obtained in 100 individuals who include 15 patients with benign tumor and 81 patients with malignancy tumor and 4 as control subjects. Liver perfusion parameters included blood flow (BF), blood volume (BV), mean transit time (MTT), permeability surface (PS) ,Hepatic Perfusion index (HPI) and Hepatic Arterial Perfusion(HAP)were calculated to evaluate the dynamic features of liver tumors.Results Compared with benign tumor of liver and control group, HPI,BF and HAP in malignancy tumor group were increased significantly, and MTT was decreased significantly. BV and PS had no difference between liver tumors and control group.Conclusion Hepatic perfusion parameters (HPI,BF, HAP and MTT) measured with CT can be used to evaluate the dynamic features in liver tumors, which have importance clinic value in differentiate diagnosis of benign or malignancy tumor.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the changes of MSCT perfusion parameters of benign or malignancy tumor in liver and discuss differentiate diagnosis.Materials and Methods CT perfusion of the liver were obtained in 100 individuals who include 15 patients with benign tumor and 81 patients with malignancy tumor and 4 as control subjects. Liver perfusion parameters included blood flow (BF), blood volume (BV), mean transit time (MTT), permeability surface (PS) ,Hepatic Perfusion index (HPI) and Hepatic Arterial Perfusion(HAP)were calculated to evaluate the dynamic features of liver tumors.Results Compared with benign tumor of liver and control group, HPI,BF and HAP in malignancy tumor group were increased significantly, and MTT was decreased significantly. BV and PS had no difference between liver tumors and control group.Conclusion Hepatic perfusion parameters (HPI,BF, HAP and MTT) measured with CT can be used to evaluate the dynamic features in liver tumors, which have importance clinic value in differentiate diagnosis of benign or malignancy tumor.

Key concepts: Medicine, Perfusion, Malignancy, Perfusion scanning, Radiology, Blood flow, Liver tumor, Arterial perfusion

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinic Application with MSCT Perfusion in Liver Tumor — Research Paper | ScholarLens